• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Imaging and Intervention

Time from symptom onset may not predict infarct volume in stroke

byDavid WangandDylan Wolman
July 21, 2015
in Imaging and Intervention, Neurology
Reading Time: 3 mins read
Time from symptom onset may not predict infarct volume in stroke
Share on FacebookShare on Twitter

1. In a prospective cohort study of 91 patients with anterior circulation ischemic strokes that underwent magnetic resonance imaging (MRI), time of stroke onset was not significantly associated with size of core infarct volume on MRI.

2. The presence of collateral circulation was significantly associated with decreased infarct volume.

Evidence Rating Level: 2 (Good)

Study Rundown: The management of acute ischemic stroke requires a timely diagnosis as administration of intravenous tissue plasminogen activator (tPA) within 4.5 hours of symptom onset or early endovascular therapy has been shown to improve outcomes. However, it is unclear whether important predictors of clinical outcome, such as infarct volume on MR imaging, have a similar time-dependent relationship. The purpose of this trial was to determine the independent predictors of infarct volume on MR imaging. This trial retrospectively analyzed 91 consecutive patients who presented with anterior circulation ischemic strokes that underwent computed tomography (CT), CT angiography (CTA), and MRI within 6 hours of presentation and compared infarct volumes between those that received imaging from 0-3 hours and 3-6 hours after presentation. At the conclusion of the trial, the median infract volume on MR imaging was similar between the 2 time points. Furthermore, there was no significant association between time of onset of symptoms and MR imaging infarct area. Multivariate analysis demonstrated that the presence of collateral circulation on CTA was an independent predictor of smaller MRI infarct volume. The results of this study support the hypothesis that time from stroke onset do not determine the size of core infarct and that underlying anatomic factors may play a role in determining the size of initial infarction and subsequent at-risk or so-called penumbral tissue. However, the study is limited by the retrospective design and small sample size as well as a lack of accurate record of time of symptom onset. Additional large, prospective trials are needed to verify this association, and to determine which other factors, if any, may contribute to greater core infarct size.

Click to read the study in AJNR

Relevant Reading: Time and diffusion lesion size in major anterior circulation ischemic strokes

RELATED REPORTS

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

Thrombectomy may improve functional independence in acute ischemic stroke with medium vessel occlusion

2 Minute Medicine Rewind April 20, 2026

In-Depth [prospective cohort]: This study was a retrospective analysis of 91 consecutive patients presenting with ischemic stroke in a single-center, acute stroke database from March 2008 to April 2013. The inclusion criteria were patients with anterior circulation strokes with MR imaging performed within 6 hours of symptom onset.  All patients in the database received CT, CTA, and MR imaging for assessment of infarct volume and ischemic penumbra. The primary endpoint was size of ischemic infarct on MRI imaging between imaging from 0-3 hours versus 3-6 hours from onset. Size of ischemic infarcts were calculated from diffusion weighted imaging sequences read by 4 independent, blinded vascular neurologists. At the conclusion of the study, there were no differences in infarct volume between the 2 MR imaging time points (24.7mL vs. 29.4mL, p=0.906). There was no association between time of stroke onset and MR core infarct volume with ROC curve analysis (area under the curve = 0.509). Multivariate analysis of clinical characteristics demonstrated that collateral circulation on CTA (OR: 0.464; 95% CI: 0.3 to 0.8; p = 0.03) and prior histories of hyperlipidemia (OR: 11.0; 95% CI: 1.4 to 88.0; p = 0.023) were independent predictors of MR core infarct volume.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Computed Tomography (CT)ischemic strokeMagnetic Resonance Imaging (MRI)
Previous Post

Prescription of antibiotics for acute respiratory infections increasing

Next Post

2 Minute Medicine Rewind July 13 – July 19, 2015

RelatedReports

Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
No obesity paradox found between BMI, stroke, and death
Neurology

Thrombectomy may improve functional independence in acute ischemic stroke with medium vessel occlusion

May 26, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Weekly Rewinds

2 Minute Medicine Rewind April 20, 2026

April 20, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Chronic Disease

Virtual reality rehabilitation is safe and feasible for upper extremity recovery after subacute ischemic stroke

February 25, 2026
Next Post
Higher blood pressure targets in sepsis did not reduce mortality

2 Minute Medicine Rewind July 13 – July 19, 2015

Allopurinol for asymptomatic hyperuricemia associated with hypersensitivity reactions

Allopurinol for asymptomatic hyperuricemia associated with hypersensitivity reactions

Bystander and first-responder initiated CPR associated with improved outcomes

Bystander and first-responder initiated CPR associated with improved outcomes

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Prognostic associations of anthropometric indices vary by clinical outcomes
  • Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
  • Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.